The emerging role of serum/glucocorticoid-regulated kinases in cancer

gan Castel, Pau, Scaltriti, Maurizio
Cyhoeddwyd yn Cell Cycle (2016)

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy

gan Scaltriti, Maurizio, Elkabets, Moshe, Baselga, José
Cyhoeddwyd yn Clin Cancer Res (2016)

NTRK fusion-positive cancers and TRK inhibitor therapy

gan Cocco, Emiliano, Scaltriti, Maurizio, Drilon, Alexander
Cyhoeddwyd yn Nat Rev Clin Oncol (2018)

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism

gan Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S
Cyhoeddwyd 2011

A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast cancer

gan Gómez Tejeda Zañudo, Jorge, Scaltriti, Maurizio, Albert, Réka
Cyhoeddwyd yn Cancer Converg (2017)

Quantification of HER family receptors in breast cancer

gan Nuciforo, Paolo, Radosevic-Robin, Nina, Ng, Tony, Scaltriti, Maurizio
Cyhoeddwyd yn Breast Cancer Res (2015)

Prevalence and role of HER2 mutations in cancer

gan Cocco, Emiliano, Lopez, Salvatore, Santin, Alessandro D., Scaltriti, Maurizio
Cyhoeddwyd yn Pharmacol Ther (2019)

AKT signaling in ERBB2-amplified breast cancer

gan Carmona, F Javier, Montemurro, Filippo, Kannan, Srinivasaraghavan, Rossi, Valentina, Verma, Chandra, Baselga, José, Scaltriti, Maurizio
Cyhoeddwyd yn Pharmacol Ther (2015)

Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment

gan Castel, Pau, Toska, Eneda, Zumsteg, Zachary S, Carmona, F Javier, Elkabets, Moshe, Bosch, Ana, Scaltriti, Maurizio
Cyhoeddwyd yn Mol Cell Oncol (2014)

Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin

gan Caccamo, Alessandro E., Scaltriti, Maurizio, Caporali, Andrea, D'Arca, Domenico, Scorcioni, Francesca, Astancolle, Serenella, Mangiola, Massimo, Bettuzzi, Saverio
Cyhoeddwyd 2004

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation

gan Anido, Judit, Scaltriti, Maurizio, Bech Serra, Joan Josep, Josefat, Belén Santiago, Rojo Todo, Federico, Baselga, José, Arribas, Joaquín
Cyhoeddwyd 2006

Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance

gan Wehrenberg-Klee, Eric, Turker, N. Selcan, Heidari, Pedram, Larimer, Benjamin, Juric, Dejan, Baselga, José, Scaltriti, Maurizio, Mahmood, Umar
Cyhoeddwyd yn J Nucl Med (2016)

Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex

gan Xie, Wei, Wang, Shengliu, Wang, Juncheng, de la Cruz, M. Jason, Xu, Guotai, Scaltriti, Maurizio, Patel, Dinshaw J.
Cyhoeddwyd yn Proc Natl Acad Sci U S A (2021)

ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins

gan Alcon, Clara, Zañudo, Jorge Gómez Tejeda, Albert, Reka, Wagle, Nikhil, Scaltriti, Maurizio, Letai, Anthony, Samitier, Josep, Montero, Joan
Cyhoeddwyd yn Cells (2021)

TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS

gan Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald
Cyhoeddwyd 2013

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

gan Chandarlapaty, Sarat, Sawai, Ayana, Scaltriti, Maurizio, Rodrik-Outmezguine, Vanessa, Grbovic-Huezo, Olivera, Serra, Violeta, Majumder, Pradip K., Baselga, Jose, Rosen, Neal
Cyhoeddwyd 2011

mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling

gan Rodrik-Outmezguine, Vanessa S., Chandarlapaty, Sarat, Pagano, Nen C., Poulikakos, Poulikos I., Scaltriti, Maurizio, Moskatel, Elizabeth, Baselga, José, Guichard, Sylvie, Rosen, Neal
Cyhoeddwyd 2011

Systematic functional characterization of resistance to PI3K inhibition in breast cancer

gan Le, Xiuning, Antony, Rajee, Razavi, Pedram, Treacy, Daniel J., Luo, Flora, Ghandi, Mahmoud, Castel, Pau, Scaltriti, Maurizio, Baselga, Jose, Garraway, Levi A.
Cyhoeddwyd yn Cancer Discov (2016)

Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

gan Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea
Cyhoeddwyd yn Nat Commun (2017)

Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

gan Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea
Cyhoeddwyd yn Nat Commun (2018)